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Background: Amycolatopsis orientalis is the type species of the genus and its industrial strain HCCB10007, derived
from ATCC 43491, has been used for large-scale production of the vital antibiotic vancomycin. However, to date,
neither the complete genomic sequence of this species nor a systemic characterization of the vancomycin
biosynthesis cluster (vcm) has been reported. With only the whole genome sequence of Amycolatopsis mediterranei
available, additional complete genomes of other species may facilitate intra-generic comparative analysis of the genus.
Results: The complete genome of A. orientalis HCCB10007 comprises an 8,948,591-bp circular chromosome and a
33,499-bp dissociated plasmid. In total, 8,121 protein-coding sequences were predicted, and the species-specific
genomic features of A. orientalis were analyzed in comparison with that of A. mediterranei. The common characteristics
of Amycolatopsis genomes were revealed via intra- and inter-generic comparative genomic analyses within the domain
of actinomycetes, and led directly to the development of sequence-based Amycolatopsis molecular chemotaxonomic
characteristics (MCCs). The chromosomal core/quasi-core and non-core configurations of the A. orientalis and the
A. mediterranei genome were analyzed reciprocally, with respect to further understanding both the discriminable
criteria and the evolutionary implementation. In addition, 26 gene clusters related to secondary metabolism, including
the 64-kb vcm cluster, were identified in the genome. Employing a customized PCR-targeting-based mutagenesis
system along with the biochemical identification of vancomycin variants produced by the mutants, we were able to
experimentally characterize a halogenase, a methyltransferase and two glycosyltransferases encoded in the vcm cluster.
The broad substrate spectra characteristics of these modification enzymes were inferred.
Conclusions: This study not only extended the genetic knowledge of the genus Amycolatopsis and the biochemical
knowledge of vcm-related post-assembly tailoring enzymes, but also developed methodology useful for in vivo studies
in A. orientalis, which has been widely considered as a barrier in this field.
Keywords: Amycolatopsis orientalis, Complete genome sequencing, Molecular taxonomic characteristics, Vancomycin
biosynthesis* Correspondence: whjiang@sibs.ac.cn; hccb001@163.com; gpzhao@sibs.ac.cn;
181zhao@163.com
†Equal contributors
3CAS Key Laboratory of Synthetic Biology, Institute of Plant Physiology and
Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of
Sciences, Shanghai 200031, China
2Shanghai Laiyi Center for Biopharmaceutical R&D, Shanghai 200240, China
Full list of author information is available at the end of the article
© 2014 Xu et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Xu et al. BMC Genomics 2014, 15:363 Page 2 of 18
http://www.biomedcentral.com/1471-2164/15/363Background
Amycolatopsis orientalis is a Gram-positive filamentous
actinomycete that produces vancomycin (Figure 1), which
is a potent glycopeptide antibiotic that has been used for
more than three decades for the treatment of serious
methicillin-resistant Staphylococcus aureus (MRSA) infec-
tions [1]. However, the reports of increased emergence of
vancomycin-resistant S. aureus (VRSA) and vancomycin-
resistant enterococci (VRE) in recent years have presented
an urgent challenge to human health, which requires theFigure 1 Morphological differentiation of mycelia in Amycolatopsis or
variants. Scanning electron micrograph of A. orientalis HCCB10007 cultured
arrow indicates the sporulation of A. orientalis cultured for three days. The
(upper right of the panel) shows minor modifications of the heptapeptide
radical compositions of each vancomycin variant compounds. Alphabetic ndevelopment of new antibiotics against these pathogens
[2-5]. Although some semisynthetic lipoglycopeptide anti-
biotics, such as telavancin, oritavancin and dalbavancin
have been developed recently and their anti-VRSA activ-
ities proved in vitro [6], the in vivo potency of these
antibiotics is yet to be demonstrated specifically by
clinical studies. Thus, further discovery and develop-
ment of new glycopeptide type drug candidates con-
tinues to be an important mission for biologists and
organic chemists.ientalis HCCB10007 and chemical structures of vancomycin
for one or three incubation days (upper left of the panel). The red
core structural formula proposed for vancomycin and its variants
core of vancomycin. Table below shows the specific formulae and
umbering in the table are corresponding to the legend of Figure 6.
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chloroeremomycin (cep) in A. orientalis A82846 and bal-
himycin (bal) in Amycolatopsis balhimycina DSM 5908,
both of which possess an identical heptapeptide back-
bone and similar antibiotic activities compared with vanco-
mycin, were completely (cep, NCBI accession number:
AJ223998, AJ223999, and AL078635) or partially (bal,
NCBI accession number: Y16952) sequenced and anno-
tated about 10 years ago [7,8]. Thereafter, a series of genes
from the two clusters, especially those encoding the post-
assembly tailoring enzymes involved in chlorination [9],
glycosylation [10-13], and methylation [14], were charac-
terized sequentially. For example, the crystal structures
of the TDP-epi-vancosaminyltransferase, GtfA [12]; the
UDP-glucosyltransferase, GtfB [11]; and the glycopeptide
N-methyltransferase, MtfA [14] from A. orientalis A82846
were resolved. The methylation function of MtfA from A.
orientalis A82846 in the synthesis of glycopeptide antibi-
otics was studied in Streptomyces toyocaensis [14], and the
halogenase activity of BhaA from A. balhimycina DSM
5908 was verified in vivo [9]. Of the enzymes encoded
by the biosynthetic gene cluster of vancomycin (vcm) in
A. orientalis ATCC 43491, in vitro experiments demon-
strated that GtfE is responsible for the addition of
D-glucose to the hydroxyl of 4-hydroxyphenylglycine and
that GtfD can transfer the L-vancosamine moiety to vari-
ant glucosyl-peptides as its substrates [10,15]. In fact, as
early as 1997, the A. orientalis GtfE was expressed in
S. toyocaensis, and a hybrid glycopeptide antibiotic, namely
glucosyl A47934, was produced [16]. However, unlike
A. balhimycina, A. orientalis is not amenable for genetic
manipulations because of difficulties encountered in DNA
transformation [17]. Therefore, most genes of the vcm
cluster have been characterized by heterologous expres-
sion or in vitro enzymatic/structural analysis [15,18,19],
with little in vivo data reported.
To date, the DNA sequences, along with their annota-
tion information, have been provided for vcm cluster
genes including those encoding the monooxygenases
(NCBI accession number: AF486630.1, FJ532347.1), the
halogenase (NCBI accession number: FJ532347.1), the
glycosyltransferases (NCBI accession number: U84350.1)
and the vancomycin-resistance proteins (NCBI accession
number: AF060799.1). Of these, the functions of the
monooxygenase (OxyB [19]), glycosyltransferases (GtfE
and GtfD [10,15,16]), and the vancomycin-resistance
proteins (VanHAX [20,21]) have been well characterized.
We cloned and sequenced the whole vcm gene cluster in
2010 (NCBI accession number: HQ679900.1). However,
with the exception of the glycosyltransferases and their
encoding genes [10,15], other post-assembly tailoring en-
zymes encoded in the vcm cluster, such as the halogenase
and the methyltransferase, have been barely experimen-
tally characterized so far and their functions are onlyassumed based on the similarity of the proteins to those
encoded by bal or cep [9,14].
The complete genome sequences of the rifamycin pro-
ducers Amycolatopsis mediterranei [22,23] not only revealed
the special genomic features of the genus Amycolatopsis,
but also confirmed it as a clade of rare actinomycetes
potentially rich in antibiotic production capabilities. How-
ever, although three draft datasets for the genomes of
A. orientalis subsp. orientalis were released recently [22,23],
neither the annotation nor genomic analysis for these gly-
copeptide antibiotic-producing Amycolatopsis strains is
available to date, particularly, at the level of the complete
genome sequence. Here, we report the whole genome
sequence of an industrial strain (HCCB10007) of A.
orientalis (CP003410 and CP003411). This strain pro-
duces high yields of vancomycin, and is derived from
the species type strain ATCC 43491 through series of
physical and chemical mutageneses. The high-quality
complete genome sequence of A. orientalis was com-
pared intra- and inter-generically to those of its close
or distant phylogenetic relatives within the domain of ac-
tinomycetes to characterize species-specific and genus-
common features of the genomes. Moreover, functions of
the predicted halogenase and methyltransferase of the
vcm cluster in A. orientalis were characterized via robust
spectroscopic analyses in the corresponding site-specific
mutants, generated by a customized homologous recom-
bination mutation method.
Results and discussion
General and species-specific features of the complete
A. orientalis genome
The genome of A. orientalisHCCB10007 comprises two repli-
cons (Figure 2), a large circular chromosome (8,948,591 bp)
and a small, dissociated circular plasmid (33,499 bp). The
same circular chromosomal topology with that of A. medi-
terranei U32 [24] and A. mediterranei S699 [25,26], which
are the other two complete genomes of the Amycolatopsis
genus currently available, implies that this is a common
topological feature that differs from the Streptomyces
linear chromosomes [27]. The genome of A. orientalis
HCCB10007 is much smaller (1.3 Mbp) than that of A.
mediterranei, and only 8,121 protein-coding sequences
(CDSs) were predicted, which is approximately 1,100
fewer CDSs than those identified in the genome of A.
mediterranei (Table 1). The difference is mainly accounted
for ~1.1 Mbp shorter in the length of the non-core regions
of A. orientalis. Furthermore, this difference is also en-
hanced to a certain extent (about 0.2 Mbp) by the smaller
average size of the intergenic region (IR) both in the core
and the non-core regions of the A. orientalis genome
(Table 1), resulting in a more compact arrangement of
genes (coding density of 90.4%) compared with that of
A. mediterranei (89.1-89.3%).
Figure 2 Genome atlas of the A. orientalis and gene clusters for secondary metabolism. The large circle represents the chromosome: the
outer scale is numbered in megabases and indicates the core (red), quasi-core (orange), and non-core (sky blue) regions. The circles are
numbered from the outside in. The genes in circles 1 and 2 (forward and reverse strands, respectively) are color-coded according to COG
functional categories. Circle 3 shows selected essential genes (cell division, replication, transcription, translation, and amino-acid metabolism; the
paralogs of essential genes in the non-core regions are not included). Circle 4 shows the secondary metabolic clusters, which are further
enlarged outside the circle for detailed illustration. The vcm cluster is further illustrated in Figure 6. Circle 5 depicts the RNAs (blue, tRNA;
red, rRNA). Circle 6 shows the mobile genetic elements (transposase, phage). Circle 7 depicts the GC content. Circle 8 shows the GC bias
(pink, values > 0; green, values < 0). The small circle on the right side represents the plasmid DNA sequence. The outer scale is numbered
in kilobases. All of the genes, regardless of the forward or reverse strands, are illustrated in the same circle. Circles 2 and 3 are the same
as circles 7 and 8 of the large chromosome, respectively.
Table 1 General features of the Amycolatopsis genomes
Species A. orientalis A. mediterranei
Strain HCCB10007 U32 S699
Length (bp) 8,948,591 10,236,715 10,246,920
Core/quasi-core vs Noncore (Mbp) 5.9 3.0 6.1 4.1 6.1 4.1
GC content 69.0% 71.3% 71.3%
Core/quasi-core vs Noncore 69.0% 69.0% 71.1% 71.6% 71.1% 71.6%
ORFs Total 8,121 9,228 9,227
Core/quasi-core vs Noncore 5,624 2,497 5,627 3,601 5,630 3,597
Proteins with function assigned 5,518 (67.9%) 6,441 (69.8%) 6,386 (69.2%)
Hypothetical proteins with unknown function 2,603 (32.1%) 2,787 (30.2%) 2,841 (30.8%)
Average ORF size (bp) 996 990 989
Core/quasi-core vs Noncore 955 1,089 966 1,027 965 1,027
Average Intergenic region size (bp) 105 119 121
Core/quasi-core vs Noncore 101 116 115 126 118 126
Coding density (%) 90.4% 89.3% 89.1%
Core/quasi-core vs Noncore 90.5% 90.3% 89.4% 89.1% 89.0% 89.1%
RNA rRNA operons 4 4 4
Core/quasi-core vs Noncore 4 0 4 0 4 0
tRNA genes 50 52 52
Core/quasi-core vs Noncore 41 9 41 11 41 11
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starting point for the numbering of the total CDSs in clock-
wise order (Figure 2). We assigned 5,518 CDSs (67.9%) to
known or putative functions, whereas the remaining 2,603
CDSs (32.1%) were annotated as genes encoding hypo-
thetical proteins (Table 1). The dissociated plasmid (desig-
nated as pXL100) encodes 49 genes, of which 43 are
functionally unknown. Similar to A. mediterranei, the A.
orientalis genome contains four rRNA operons (16S-23S-
5S), and their 16S RNA sequences are at the range of 97%
identical (Additional file 1: Table S1). Comparing the four
rRNA operons within the A. orientalis genome, the first
two, counted clockwise from dnaA, are both transcribed
in the forward direction and their 16S rRNA sequences
are slightly different (98–99% identity). The second
two are transcribed from the reverse strand and share
identical sequences for their 16S rRNAs (Additional
file 1: Table S1). A. orientalis has 50 tRNA genes, which
are largely similar to those of A. mediterranei, both in the
chromosomal location and anticodon constitutions, with
only a few exceptions, such as one less arginine and tyro-
sine tRNA genes and one more glutamic acid tRNA
gene. It is worth emphasizing that, unlike A. mediterranei,
no selenocysteine tRNA (tRNASec) was found in the
A. orientalis genome. Correspondingly, genes encoding
selenocysteine synthase (selA), elongation factor (selB),
and selenophosphate synthase (selD) were not found in
the A. orientalis chromosome. Formate dehydrogenase,
which has a selenocysteine (Sec)-encoding UGA codon
found in the A. mediterranei genome, is also absent in
A. orientalis. Compared with A. mediterranei, A. orientalis
demonstrates a clearer sporulation phenotype (Figure 1).
Although the genes responsible for this phenotypic differ-
ence are yet to be thoroughly defined, two genes, spsF
(AORI_0253) and spsG (AORI_0254), encoding spore coat
proteins, were identified only in the genome of A. orienta-
lis. In contrast, the two pMEA100-like integrated plasmids
found in the A. mediterranei genomes are absent from the
genome of A. orientalis, whereas the free plasmid pXL100
present in A. orientalis HCCB10007 is not found in any
other sequenced Amycolatopsis strains.
Reciprocal BLASTP was used to calculate the ortho-
logs between A. orientalis and other related actinomy-
cetes (A. mediterranei S699 and U32, Amycolatopsis sp.
ATCC 39116, Saccharopolyspora erythraea, Streptomyces
coelicolor, Saccharomonospora viridis, Nocardia farci-
nica, and Mycobacterium tuberculosis; Additional file 1:
Figure S1). By employing a relatively strict condition
(identity > 30%, length coverage > 80%), A. mediterranei
(U32 or S699) shares 50.3% of the total CDSs (4,642 or
4,650) as orthologs with A. orientalis, which is the high-
est among all of the comparisons of the selected actino-
mycetes. The genome of Amycolatopsis sp. ATCC 39116
was recently sequenced by the DOE Joint Genome Institute(JGI) [28], and a high-quality draft with 11 contigs was re-
leased in GenBank (accession no. AFWY00000000). We
annotated it online using the fully automated service
RAST [29] and found that, for the 8,328 predicted CDSs,
Amycolatopsis sp. ATCC 39116 shares 4,165 orthologs
(50.0%) with A. orientalis (Additional file 1: Figure S1)
S. erythraea shared 2,871 orthologs (39.9%) with A. orien-
talis, which is the second highest number among se-
quenced actinomycetes other than that of Amycolatopsis,
coincides with the close phylogenetic relationship between
the two genera (Saccharopolyspora vs. Amycolatopsis).
Although S. viridis shares only 2,318 orthologs with
A. orientalis, with its small chromosome (4.3 Mbp) en-
coding 3,828 proteins, the genus Saccharomonospora
represented by S. viridis is still considered phylogen-
etically close to Amycolatopsis, sharing an extremely high
percentage (approximately 60.6%) of orthologs, even higher
than that between any two species of the same genus
(Additional file 1: Figure S1).
Genome configuration and plasticity of A. orientalis
compared with A. mediterranei
The unique chromosomal configuration consisting of
core versus non-core regions characterized by the dis-
tinct features in gathering of essential genes (i.e., genes
coding for functions of cell division, replication, tran-
scription, translation, and amino-acid metabolism) in
the corresponding genomic regions was first recog-
nized in the linear genome of S. coelicolor [30] and then
in the circular chromosome of S. erythraea [31]. Recently,
a novel “quasi-core” region, with typical core charac-
teristics, was defined within the non-core region of the
A. mediterranei U32 genome, along with the propos-
ition of three discriminable criteria, including the gather-
ing of essential genes, the discrepancy in coding density of
orthologous genes and the co-linearity of the orthologs’
order [24]. In this study, taking the advantage of the avail-
ability of the complete genome sequences of two species
(A. orientalis and A. mediterranei) from the same genus,
the chromosomal configuration of these species was ana-
lyzed using more rigorous statistical methods, and special
genomic plasticity related to major antibiotics produc-
tion was revealed as probable chromosomal recombin-
ation events.
First, a core region of A. orientalis genome (nucleotide
coordinates of 0-3.1 Mbp and 6.3-8.9 Mbp, corresponding
to AORI_0001-AORI_2890 and AORI_5565-AORI_8121)
was recognized by its good co-linearity of the order of its
orthologs, with 14.5% of coding density for essential genes
compared with 10.2% in non-core regions (P < 0.01).
Meanwhile, the coding density of orthologous genes in the
core region (68.2%) was also higher than that in the non-
core regions (37.3%) (P < 0.01) (Figure 3A, Additional
file 1: Table S2).
Figure 3 (See legend on next page.)
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Figure 3 Genome configurations of A. orientalis and A. mediterranei. (A) All of the dots in the panels were calculated in a 90-kb sliding
window. For the broken X plot (lower right of the panel), the dots represent a reciprocal best match between the genomes of A. orientalis and
A. mediterranei, based on the BLASTP comparison. The X-axis (Y-axis) is the nucleotide scale of the A. orientalis (A. mediterranei) chromosome.
R1 (4.02-4.28 Mb, AORI_3663-AORI_3909) and R2 (5.55-5.75 Mbp, AORI_4997-AORI_5173) were designated as the two quasi-core regions in the
A. orientalis genome. Reciprocally, two regions (AMED_4864-AMED_5049 and AMED_5970-AMED_7071) were defined as the quasi-core in the
A. mediterranei genome. The core and quasi-core regions are highlighted in lavender (A. orientalis) or in pink (A. mediterranei). P1 to P4 were
designated as the regions containing biosynthesis clusters of rifamycin (rif in A. mediterranei), vancomycin (vcm in A. orientalis), NRPS (nrps10 in
A. mediterranei) and polyketide (pks9 in A. orientalis), respectively. In the upper right and lower left panels, the pink triangles represent the coding
density of all of the genes; the turquoise squares represent the coding density of orthologs between the genomes of A. orientalis and A. mediterranei;
and the yellow circles represent the coding density of the essential genes. The area within the black square frame is the P2 region containing the vcm
cluster, with a lower coding density of orthologs and essential genes. (B) Alignment of the P2 region with its flanking genes related to the vancomycin
biosynthesis in selected actinomycete genomes. The green arrows represent the omitted genes in the corresponding genomes. (C) Alignment
of the P1 region with its flanking genes related to the rifamycin biosynthesis in selected actinomycete genomes. All of the genome data are
available at NCBI.
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nomes of A. mediterranei and S. erythraea, two quasi-
core regions (R1 and R2) within the non-core of the A.
orientalis genomes are defined compared with that of A.
mediterranei (Figure 3A). The gene orders in these two
regions show good conservation with those of A. medi-
terranei and the coding density of orthologous genes is
67.0% (R1, P < 0.05) and 73.3% (R2, P < 0.01), respect-
ively, significantly higher than that of the non-core
regions (Additional file 1: Table S2). In addition, the
coding density of essential genes in these two regions is
also higher than that in the non-core regions (10.2%),
reaching 16.0% (R1, P ≈ 0.05) and 22.3% (R2, P < 0.05),
respectively (employing 45-kb instead of 90-kb slid-
ing window size for statistical analysis, as shown in
Additional file 1: Table S2). It is worth mentioning that
the identification of two quasi-cores is reciprocal, i.e., two
regions (AMED_4864-AMED_5049 and AMED_5970-
AMED_7071) can be defined as the quasi-cores in the
A. mediterranei genome by comparison with the gen-
ome of A. orientalis (Figure 3A), which was obviously
unrecognized previously when the genomes of differ-
ently related species were compared [24]. In particular,
we noticed that all of the four rRNA operons of both
species are located in either the core or quasi-core regions
(Additional file 1: Table S1 and Figure 2), as are 41 of the
50 tRNA genes of A. orientalis (52 of A. mediterranei)
containing the codons for all 20 essential amino acids
(Table 1).
Comparing the genome of A. orientalis with that of A.
mediterranei, a large inversion usually known as the “X
pattern” was revealed. Although the order of orthologs is
well conserved between these two species, the line of the
“X pattern” is not consecutive and is often interspersed
with break points. Most of the break points are within
the non-core regions encoding the majority of the sec-
ondary metabolite biosynthesis gene clusters (Figure 2
and Figure 3A), which might represent some horizontal
gene transfer events. The rare break points embedded inthe core regions, termed P1 to P4, are usually the regions
containing gene clusters for the synthesis of the “species-
specific” secondary metabolites, i.e., rifamycin (rif ) in
P1 of A. mediterranei and vancomycin (vcm) in P2 of
A. orientalis (Figure 3A). The P2 region in A. orientalis
is nearly 300 kb in length. It not only contains the 64 kb
vcm cluster, but also encodes many hypothetical pro-
teins or predicted transcriptional regulators, and thus
shows a relatively low coding density of orthologs and
essential genes. In contrast, the corresponding region of
A. mediterranei contains dozens of CDSs (over less than
100 kb), including two gene pairs of transposase/integrase
(AMED_1442-AMED_1443 and AMED_1452-AMED_1453;
Figure 3B). The AMED_1452-AMED_1453 gene pair is a
duplicate of AMED_1442-AMED_1443 with a reversed
transcription direction, which indicates that an insertion
might have occurred in the P2 region of an ancestral
strain, which resulted in the acquisition of the vcm gene
cluster in A. orientalis. Unlike the P2 flanking regions, the
two regions flanking the rif cluster of P1 are highly con-
served among the Amycolatopsis species (Figure 3C). As
indicated by the alignments, the rif cluster appears to be
inserted between two genes encoding a conserved hypo-
thetical protein (AMED_0612) and the unique DNA-
directed RNA polymerase β subunit (RpoB, AMED_0656).
Therefore, we speculate that the ancestor of A. mediterra-
nei may have acquired the rif cluster more recently than
that occurred in P2. In addition, a LuxR-like tran-
scriptional regulator (AMED_0655) is located between
the 3’ end of the rif cluster and the conserved rpoB
gene (Figure 3C), which seems to have been acquired
simultaneously with the rif cluster by the ancestral strain.
A potential regulatory function of this LuxR-like protein
in rifamycin biosynthesis is inferred, and the correspond-
ing experimental proof is currently being pursued (unpub-
lished data).
In this study, intra-generic comparative genomic analysis
of Amycolatopsis not only confirmed the core/quasi-core
and non-core genomic configuration, but also discovered
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should be noted that the definition of core, quasi-core, or
non-core regions of a genome so far remains a relative
concept with respect to the genomes of certain species or
genera to be compared. The choice of the sliding window
size could also influence the characterization of the gen-
omic configuration, which was clearly demonstrated
in the case of comparing the coding density of essen-
tial genes between the quasi-core and non-core regions.
When the window size used in the analysis was reduced
from 90-kb to 45-kb, thus doubling the sample size, the
P-values were reduced from more than one to ≤ 0.05
(Additional file 1: Table S2). In our opinion, these flexible
categorizations are somewhat artificial; however, they are
useful tools to infer different processes of evolution of a
genus or of microevolution of a species. The quasi-core
region(s) may represent the residue(s) of the complex evo-
lution dynamics (vertical genomic recombination events)
of the ancestral genome, while the non-core regions may
represent the chromosomal expansions (horizontal gene
transfer) in the various descendants’ genomes. As more
whole genome sequences of different strains of one spe-
cies or different species of one genus, as well as those
from closely related genera, are published, the biological
implications of this genomic plasticity in bacterial phyl-
ogeny will be clarified.
Development of molecular chemotaxonomic
characteristics (MCCs) for the genus of Amycolatopsis
The taxonomic status of A. orientalis underwent the same
revision history as that of A. mediterranei [24]; i.e., it was
originally considered a streptomycete [32], then trans-
ferred to Nocardia [33], and finally classified as a species
of the newly established genus Amycolatopsis [34], which
was typically defined by the biochemical characteristics of
its cell wall (chemotype IV) and cell membrane (chemo-
type II). As initiated in the study of the A. mediterranei
U32 genome [24], in addition to the molecular genetic
basis responsible for the components of arabinose, glycine,
diaminopimelic acids and mycolic acids (Additional file 1:
Table S3, Additional file 1: Table S4, Additional file 1:
Figure S2, and Additional file 1: Figure S3), we attempted
to analyze the previously unidentified genetic basis of
two more chemotaxonomic phenotypes, i.e., phospho-
lipids and menaquinones.
The cell membrane of actinomycetes is classified into
five types according to the presence of certain nitro-
genous phospholipids [35]. The Amycolatopsis cell mem-
brane belongs to the PII type because only one nitrogenous
phospholipid, namely phosphatidyl ethanolamine (PE),
was usually detected in its cell membrane [35]. In pro-
karyotes, phosphatidylserine is first generated from
CDP-diacylglycerol, a general intermediate for the synthe-
sis of different types of phospholipids, catalyzed byphosphatidylserine synthase (PssA, EC: 2.7.8.8), and is
then transformed into PE [36,37] by phosphatidylserine
decarboxylase (Psd, EC: 4.1.1.65) (Figure 4A). Orthologs
of both pssA (AORI_7346) and psd (AORI_7345) could be
identified in the A. orientalis genome. These two genes
also exist in other actinomycetes with a type PII cell mem-
brane, such as A. mediterranei, N. farcinica, S. coelicolor,
and M. smegmatis, but are absent in actinomycetes with a
type PI membrane (no nitrogenous phospholipids) or
other types of cell membranes. Moreover, in the genomes
of neither A. orientalis nor A. mediterranei did we identify
genes encoding phosphatidylcholine synthase (Pcs, EC:
2.7.8.24), which catalyzes the formation of phosphatidyl
choline (PC), the characteristic type PIII phospholipid,
or the genes encoding phosphatidylglycerophosphatase
A (PgpA, EC: 3.1.3.27), which catalyzes the formation
of phosphatidyl glycerol (PG), the characteristic type
PV phospholipid (Figure 4A). It is worth mentioning
that the gene ept1, which encodes ethanolamine phos-
photransferase (EPT1, EC: 2.7.8.1) that catalyzes the
biosynthesis of PE from 1, 2-diacylglycerol and CDP-
ethanolamine in eukaryotes, is also absent in any of the se-
quenced actinomycete genomes (Figure 4A).
Isoprenoid quinones comprise a hydrophilic head and
an apolar isoprenoid side chain, functioning mainly as
electron and proton carriers in photosynthetic and respira-
tory electron transport systems [38]. These compounds
have also been used as conventional biomarkers in bacter-
ial chemotaxonomy since the 1960s [39,40]. In the synthe-
sis of isoprenoid quinones, isoprenyl diphosphate synthase
(Isp) catalyzes the consecutive condensation of isopentenyl
diphosphate (IPP) with allylic diphosphates and produces a
variety of prenyl diphosphates with different chain lengths
[38]. Previous studies reported that the specific amino-acid
residues of isoprenyl diphosphate synthases attributable
to the chain-length determination were designated the
chain-length determination (CLD) region [41]. However,
for the biosynthesis of isoprenoid quinones with longer
chain lengths (more than C30), the consensus CLD region
in isoprenyl diphosphate synthases has yet to be clarified
[41]. In actinomycetes, menaquinone (MK) is the charac-
teristic type of isoprenoid quinone in the cell membrane.
We compared the amino-acid sequences (particularly the
CLD region) of Isp from type strains of actinomycetes har-
boring different-length MKs but no regular patterns could
be found (Figure 4B). Hence, the isoprenyl diphosphate
synthases were analyzed phylogenetically using the neigh-
bor joining (NJ) method. As shown in Figure 4B, species
with MK-7 (C35) in their membranes are clustered within
one clade, whereas species with MK-8 (C40) or MK-9
(C45) are clustered together and are indistinguishable in
the tree. In addition, the maximum parsimony (MP)
method was also used to construct a phylogenetic tree.
However, the clustering result could not distinguish the
Figure 4 (See legend on next page.)
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Figure 4 Biosynthetic pathways of different types of nitrogenous phospholipids in actinomycetes. (A) The cell membrane of
Amycolatopsis belongs to the type PII because PE is the dominant phospholipid detected. Two essential proteins (AORI_7345 and
AORI_7346, labeled in red color) involved in the biosynthesis of PE were encoded by the A. orientalis genome, whereas the genes
encoding enzymes involved in other types of nitrogenous phospholipids were not found (NF). Actinomycetes of type PI contain no
nitrogenous phospholipids in their cell membrane, while type PII, type PIII, type PIV, and type PV actinomycetes contain the following
characteristic phospholipids: PE, PC, GluNU, and PG, respectively. Panel (B) illustrates the analysis of isoprenyl diphosphate synthases from
type strains of actinomycetes. The names and amino-acid sequences of the strains with different colors represent actinomycetes harboring
different-length MKs: red, MK7 (C35); olive-green, MK8 (C40); blue, MK9 (C45). The amino-acid sequences of the chain-length determination (CLD)
region are emphasized in green on the right of the panel. The protein sequences were obtained from NCBI at http://www.ncbi.nlm.nih.gov/protein/.
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Figure S4). Therefore, it is yet to be experimentally
clarified whether the genotypes of isoprenyl diphosphate
synthases, i.e., their sequence specificities, are a sufficient
determinant for all different side chain lengths of isopren-
oid quinone, or whether the variation of isoprenoid
quinones in actinomycetes is a quantitative, rather than a
qualitative, property that might be determined by gene ex-
pression regulation or other post transcription/translational
modifications.
In summary, our sequential studies in two species of
Amycolatopsis (ref to [24] and this work) indicate that
the chemotaxonomic characteristics of this genus, which
relate to, but differentiate from Streptomyces and Nocardia,
are intrinsically determined by the molecular phylogeny of
their encoding genes. On the other hand, the failure to
precisely determine the molecular genetic mechanisms
underlying the chain-length of MK hinted at the complex-
ity of these genotype/phenotype correlations. Together
with some more important chemotaxonomic characteris-
tics, such as the composition of fatty acids, these complex
phenotypes and their related molecular genetic mecha-
nisms may prompt further biochemical and molecular
biological studies. Nowadays, we propose that, based on
whole genome analysis of multiple bacterial strains be-
longing to and related with a taxon (particularly, species
or genus), potential molecular chemotaxonomic charac-
teristics (MCCs) could be developed as the genotypes
underlie the biochemical characteristics (phenotypes) of
the taxon. The implementation of MCCs in bacterial sys-
tematics will not only alleviate the tedious workload of
chemotaxonomic identification, but also improve our
understanding of the genetics of bacterial metabolomes,
which will form an indispensable portion of the modern
prokaryotic taxonomy in the era of genomics [42].
Biosynthesis of secondary metabolites and the post-assembly
modifications of vancomycin in A. orientalis
Twenty-six secondary metabolite biosynthetic gene clus-
ters were predicted in the complete genome of A. orientalis
HCCB10007, including nine type I polyketide synthase
(PKS) clusters, one type II PKS cluster, ten non-ribosomal
peptide synthetase (NRPS) clusters, three hybrid PKS-NRPS clusters, two clusters for terpenoids, one cluster
for lycopene (lyc), and one cluster for β-carotene (car)
(Figure 2). The total length of these gene clusters was esti-
mated ~552 kb, which is 6.2% of the whole genome. In
contrast to the essential genes, most of the secondary me-
tabolite biosynthetic gene clusters (18 out of 26) were in
the non-core regions (Figure 2).
To determine the possible phylogenetic relationships
of the secondary metabolites biosynthesis gene clusters,
all of the CDSs for PKSs, NRPSs, or terpene synthases
were compared against the NCBI database via BLASTP.
The best hits information is provided in Additional file
1: Table S5. Twenty-seven genes in nine biosynthetic
gene clusters (34.6% of the total 26 clusters) have ortho-
logs in the A. mediterranei genome with the best hitting
scores, i.e., car, pks1, lyc, and tps2 in the core region and
pks3, tps1, nrps7, pks5, and pks6 in the non-core regions.
Furthermore, the nrps7, pks5, and pks6 gene clusters are
closely located in the non-core region, particularly the
pks5 and pks6 clusters (Figure 2). These close correlations
between sequence similarity and genomic loci gathering
may indicate a common phylogenetic origin.
Notably, among the eight gene clusters for secondary
metabolism located in the core and quasi-core regions,
except for four clusters (car, pks1, lyc, and tps2) ortholo-
gous to those encoded in A. mediterranei genome, all of
the other A. orientalis specific clusters (vcm, pks9, nrps10,
nrps4) are located in the break point of the chromosomal
“X pattern” blocks. However, because of the small coding
size of nrps10 and nrps4, only the vcm cluster (64 kb),
located in the P2 break point, and the pks9 cluster
(AORI_6587-6642, 61.7 kb), located in the P4 break
point, could be traced in the “X pattern” blocks (Figure 3A).
The KS domains of pks9 are similar to those of the sali-
nosporamide A biosynthetic gene cluster in Salinispora
tropica CNB-440 (73% identity) [43]. This cluster is
rich in genes encoding modification enzymes, such as
glycosyltransferases, halogenase, and cytochrome P450,
which suggests the production of a glycosidic and halo-
genic compound.
In the non-core regions, cluster pks2 (AORI_2937-2956,
79.6 kb) contains a type I polyketide synthase, which was
once reported to synthesize a glycosidic polyketide ECO-
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For the other secondary metabolite biosynthesis gene clus-
ters in A. orientalis genome, their putative substrates or
probable products were predicted using catalytic do-
main analysis against the SBSPKS [45] or NRPSDB [46]
databases and the results are listed in Additional file 1:
Table S5. We isolated the total RNA of A. orientalis from
two different cultures (fermentation medium F1 and
nutrient medium F5, Additional file 1: Supplementary
Materials and Methods), and used reverse-transcription
PCR to detect the transcription profiles of the gene clus-
ters that might synthesize potential secondary metabolites.
As shown in the Additional file 1: Figure S5, in both F1
and F5 media, the genes of three clusters (pks5, n_p2, and
vcm) showed significant levels of transcription, with vcm
being the highest among all gene clusters tested. Another
cluster (nrps4) was expressed in the F1 fermentation
medium but not in the F5 medium. Although we failed to
identify any novel secondary metabolites, our data pro-
vides a foundation for further exploration.
The vcm cluster was annotated to encode a total of 35
enzymes (AORI_1471 to AORI_1505), including three
vancomycin-resistance proteins (VanH, VanA, and VanX
[7,8]), three large NRPSs, several post-assembly tailoring
enzymes, and a series of biosynthetic proteins for the sup-
ply of amino-acid precursors (Table 2). Different from the
cep and bal clusters, in which three genes encoding glyco-
syltransferases were predicted [7,8], only two glycosyl-
transferases are encoded in the vcm cluster (AORI_1486
and AORI_1487). On the other hand, the vancomycin-
resistance genes vanHAX (AORI_1471-AORI_1473) are
only predicted in vcm and not in the other two clusters
(Table 2). Throughout the A. orientalis genome, we identi-
fied another vanA (AORI_8112) and vanX (AORI_2227),
as well as a two-component system (AORI_7254-AORI_
7255) similar to the vanSR of bal that may be related to the
vancomycin resistance.
Similar to the biosynthesis of balhimycin and chloroere-
momycin, the biosynthesis of vancomycin includes three
steps [17]. The related functional genes inside and outside
of the vcm cluster were mapped to the A. orientalis gen-
ome (Figure 5). First, seven amino-acid precursors, includ-
ing one leucine, one asparagine, two β-hydroxytyrosine
(L-βHt), two 4-hydroxyphenylglycine (L-Hpg) and one
3, 5-dihydroxyphenylglycine (L-Dpg), need to be syn-
thesized. Genes encoding the enzymes responsible for the
biosynthesis of three non-protein amino acids were identi-
fied in the genome, i.e., AORI_1492-AORI_1494 for L-
βHt, AORI_1476, AORI_1491, AORI_1495-AORI_1496
for L-Hpg, and AORI_1502-AORI_1505 for L-Dpg.
Second, the seven precursor amino acids are assembled
to form a heptapeptide backbone, which are catalyzed by
the NRPSs VcmA (AORI_1478), VcmB (AORI_1479), and
VcmC (AORI_1480). These three giant enzymes containseven modules (M1-M7) with 24 domains that function in
the selection, activation, condensation and epimerization
of the amino-acid substrates [17]. In M2, M4, and M5,
there are three epimerases (E domain) that convert L-
βHt2, L-Hpg4, and L-Hpg5 into the corresponding D type
amino acids. The N-terminal amino acid of vancomycin is
D-methylleucine [47]. However, neither an epimerase nor
a dual condensation/epimerization domain [48,49] was
observed in M1 or the adjacent C domain in M2. Rausch
et al. conjectured that a racemase outside the vcm cluster
might be responsible for the conversion of L-leucine into
D-leucine, which can be incorporated directly into the gly-
copeptides [48]. Throughout the whole genome, there are
11 genes that potentially encode racemases, including six
amino-acid racemases, three CoA racemases, and two
mandelate racemases (see Additional file 1: Table S6). The
recent genomic analysis of Vibrio cholera identified a
novel PLP-dependent amino-acid racemase (vc1312) that
was proven to be necessary and sufficient for the synthesis
of the unusual D-amino acids, including D-leucine [50].
With vc1312 as the query sequence, we used the BLASTP
program to search throughout the whole genome of
A. orientalis. The results revealed one protein, annotated
as an amino-acid racemase (AORI_0725), which has 28%
amino-acid identity (48% positive) with vc1312 and that
may function in D-leucine conversion. Further experimen-
tal proof is required to confirm its involvement in vanco-
mycin synthesis.
The last step is the post-assembly modifications of the
heptapeptide backbone, including its cyclization, halo-
genation, methylation and glycosylation. Based on their
corresponding genes in the cep and bal clusters [7,8], the
functions of the modification genes in the vcm cluster
were annotated (Table 2). The oxyA/B/C (AORI_1482-
1484) genes likely encode three P450 monooxygenases
that are responsible for closing the linear peptide to
form the heptapeptide ring [19,51]. Adjacent to them,
AORI_1485 (vhal) is predicted to encode a halogen-
ase, showing 94% amino-acid sequence identity with that
encoded by the bhaA in bal [9], which chlorinates the βHt
residues. However, the exact timing of the chlorination is
unknown, although it was proposed to occur before the
oxidative couplings [52]. The methylation of D-leucine on
the α-NH2 is catalyzed by a methyltransferase, which has
been functionally characterized in the cep cluster [14]. Its
orthologous protein in the vcm cluster was found and an-
notated as Vmt (AORI_1490). Glycosylation is the last of
the modifications and the functional glycosyltransferases
for vancomycin biosynthesis have been well-characterized
biochemically [10,15]. GtfE (AORI_1487) is responsible
for the addition of the first TDP-glucose moiety to the
4'-hydroxyl group of amino acid Hpg4, and the other
glycosyltransferase GtfD (AORI_1486) adds the second
TDP-L-β-vancosamine moiety to the 2'-hydroxyl group of
Table 2 Annotation of the vcm cluster in A. orientalis and the comparison with bal and cep
AORI_CDS Gene name Annotation Best hit genes (NCBI accession no.) Identity %
AORI_1471 vanH D-lactate dehydrogenase - -
AORI_1472 vanA D-alanine-D-alanine ligase - -
AORI_1473 vanX D-alanyl-D-alanine dipeptidase - -
AORI_1474 Hypothetical protein - -
AORI_1475 vtr Regulator protein lcl|Y16952.3_cdsid_CAG25754.1 83.33
AORI_1476 pdh Prephenate dehydrogenase lcl|Y16952.3_cdsid_CAG25755.1 84.12
AORI_1477 ATP-binding cassette, subfamily B lcl|AJ223999.1_cdsid_CAA11793.1 88.89
AORI_1478 vcmA Non-ribosomal peptide synthetase lcl|AL078635.1_cdsid_CAB45052.1 81.31
AORI_1479 vcmB Non-ribosomal peptide synthetase lcl|AJ223999.1_cdsid_CAA11795.1 82.34
AORI_1480 vcmC Non-ribosomal peptide synthetase lcl|Y16952.3_cdsid_CAC48362.1 86.81
AORI_1481 mbtH MbtH protein lcl|Y16952.3_cdsid_CAC48363.1 89.86
AORI_1482 oxyA Cytochrome P450 lcl|Y16952.3_cdsid_CAA76547.1 86.19
AORI_1483 oxyB Cytochrome P450 lcl|Y16952.3_cdsid_CAA76548.1 87.44
AORI_1484 oxyC Cytochrome P450 lcl|AJ223998.1_cdsid_CAA11791.1 91.69
AORI_1485 vhal Halogenase lcl|Y16952.3_cdsid_CAA76550.1 93.89
AORI_1486 gtfD Vancosaminyl transferase lcl|Y16952.3_cdsid_CAA76553.1 69.93
AORI_1487 gtfE Glycosyl transferase lcl|Y16952.3_cdsid_CAA76552.1 81.17
AORI_1488 vcaC Methyltransferase family protein lcl|Y16952.3_cdsid_CAC48364.1 93.87
AORI_1489 LmbE family protein lcl|Y16952.3_cdsid_CAC48365.1 75.91
AORI_1490 vmt Methyltransferase lcl|AJ223998.1_cdsid_CAA11779.1 73.21
AORI_1491 hpgT 4-hydroxyphenylglycine aminotransferase lcl|AJ223998.1_cdsid_CAA11790.1 89.7
AORI_1492 vhp Hydrolase lcl|AJ223998.1_cdsid_CAA11784.1 85.87
AORI_1493 vcmD Non-ribosomal peptide synthetase lcl|AJ223998.1_cdsid_CAA11773.1 83.57
AORI_1494 oxyD Cytochrome P450 lcl|Y16952.3_cdsid_CAC48370.1 85.35
AORI_1495 hmaS 4-hydroxymandelate synthase lcl|AJ223998.1_cdsid_CAA11761.1 75.56
AORI_1496 hmo 4-hydroxymandelate oxidase lcl|Y16952.3_cdsid_CAC48372.1 85.24
AORI_1497 Antipoter lcl|Y16952.3_cdsid_CAC48373.1 80
AORI_1498 vcaA Oxidase lcl|Y16952.3_cdsid_CAC48374.1 88.04
AORI_1499 vcaE Reductase lcl|Y16952.3_cdsid_CAC48375.1 84.21
AORI_1500 vcaB Aminotransferase lcl|AJ223998.1_cdsid_CAA11782.1 88.62
AORI_1501 vcaD Epimerase lcl|Y16952.3_cdsid_CAC48377.1 85.57
AORI_1502 dpgA Polyketide synthase lcl|AJ223998.1_cdsid_CAA11765.1 92.9
AORI_1503 dpgB Isomerase lcl|Y16952.3_cdsid_CAC48379.1 75
AORI_1504 dpgC Thioesterase lcl|Y16952.3_cdsid_CAC48380.1 83.25
AORI_1505 dpgD Dehydration protein lcl|Y16952.3_cdsid_CAC48381.1 86.49
Note: “-” represents no orthologous gene was found in bal (Y16952.3) or cep (AL078635.1, AJ223999.1 and AJ223998.1) clusters.
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acid sequence similarity to BgtfB encoded by bal (81%)
and GtfB encoded by cep (81%), whereas AORI_1486
shows the highest similarity to BgtfC encoded by bal (70%)
and GtfC encoded by cep (69%). No glycosyltransferase cor-
responding to BgtfA or GtfA, which add 4-epivancosamine
to the amino-acid residue of βHt6 in bal or cep, was found
in the genome of A. orientalis. Therefore, there is no epi-
vancosamine moiety present in vancomycin (Figure 1).To characterize the in vivo functions of the predicted
halogenase, the putative methyltransferase and the glyco-
syltransferases encoded by the vcm cluster, in-frame mono-
genic mutants of AORI_1485 (vhal), AORI_1490 (vmt),
AORI_1486 (gtfD), and AORI_1487 (gtfE) are successfully
constructed using a homologous recombination method
similar to the PCR-targeting system (Methods). Various
types of vancomycin derivatives, i.e., dechlorovancomycin,
demethylvancomycin, desvancosamine vancomycin, and
Figure 5 Metabolic pathway of vancomycin biosynthesis. Three steps are involved in the biosynthesis of vancomycin, and the related functional
genes in and outside of the vcm cluster were mapped. I) The biosynthesis of its amino-acid precursors (right of the panel). Non-ribosomal peptide
synthetase VcmD (AORI_1493) catalyzes free tyrosines to form tyrosyl-S-enzyme, which is hydroxylated by OxyD (AORI_1494) and then release as βHt
by the action of Vhp (AORI_1492). Genes of pdh/hpgT/hmaS/hmO (AORI_1476, AORI_1491, AORI_1495-1496) are responsible for Hpg synthesis from
prephenate, and dpgA/B/C/D (AORI_1502-AORI_1505) are responsible for Dpg synthesis using malonyl-CoA as the starting unit. II) The modified
amino acids are assembled to form linear heptapeptide by NRPSs (VcmABC, AORI_1478-1480) with seven modules (M1-M7, upper left of the panel).
A, adenylation domain; C, condensation domain; E, epimerization domain; T, thiolation domain; TE, thioesterase domain. III) The post-modifications
of the linear heptapeptide (down the left side of the panel) include cyclization (oxyA/B/C, AORI_1482-AORI_1484), halogenation (vhal, AORI_1485),
methylation (vmt, AORI_1490), and glycosylation (gtfDE, AORI_1486-AORI_1487). Finally, vancomycin is generated.
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mutant cultures, were collected and their structures were
confirmed by high-performance liquid chromatography-
mass spectrometry (HPLC-MS) (Figure 6). Based on the
results from the zone of inhibition test, desvancosamine
vancomycin (Figure 6C), particularly dechlorovancomycin
(Figure 6B), showed a lower bioactivity relative to that
of vancomycin, whereas aglucovancomycin (Figure 6D)
showed a slightly higher bioactivity than that of vanco-
mycin. The bioactivity of demethylvancomycin (Figure 6F)
was comparable to that of vancomycin. In addition,
using demethylvancomycin or aglucovancomycin as the
substrate, dimethylvancomycin (Figure 6G) or dimethyla-
glucovancomycin (Figure 6E) were generated in vitro cata-
lyzed by the heterogeneously expressed methyltransferaseAORI_1490. Their molecular weights were also confirmed
by the HPLC-MS spectrum, and the positions of the two
methyl groups on the N terminus of leucine (Figure 1)
were further examined using nuclear magnetic reson-
ance (NMR) (Additional file 1: Table S7, Additional file 1:
Table S8). Compared with that of vancomycin (Figure 6A),
dimethylvancomycin showed a comparable antibacterial
activity. Although dimethylaglucovancomycin (Figure 6E)
is a novel compound, its activity was also similar to
that of aglucovancomycin. Taken together, both methyla-
tion and demethylation do not affect the in vitro antibacterial
activity of vancomycin or its derivatives. For glycosylation,
despite aglucovancomycin showing a slightly higher bio-
activity than that of vancomycin in vitro, the in vivo
activity was five-fold lower than that of vancomycin
Figure 6 Functional characterization and verification of the modification genes in the vcm cluster. The 64-kb vcm cluster is illustrated in
detail. AORI_1490 (vmt), AORI_1486 (gtfD), AORI_1487 (gtfE), and AORI_1485 (vhal) were replaced in-frame by selection markers, and AORI_1490
was overexpressed in vitro using demethylvancomycin/aglucovancomycin as the substrate. The vancomycin standards (A) and the corresponding
variants obtained by isolation from mutant strains or the in vitro treatments were detected by HPLC-MS: (B) dechlorovancomycin, (C) desvancosamine
vancomycin, (D) aglucovancomycin, (E) dimethylaglucovancomycin, (F) demethylvancomycin, and (G) dimethylvancomycin. The structural formulae
of the variants are shown in the table of Figure 1. A mass of 20 μg of each compound was used to assay its activity against MRSA, and the picture is
representative of three independent experiments.
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portant role in imparting enhanced pharmacokinetic
properties.
With the exception of dimethylaglucovancomycin, nearly
all of the vancomycin derivatives mentioned above have
been isolated naturally and their antibacterial activities
reported [53] and our results are in agreement with
these previous findings. However, this study provides,
for the first time, in vivo functional characterization
of the predicted halogenase, the putative methyltrans-
ferase and the biochemically-characterized glycosyltrans-
ferases in A. orientalis, along with a systemic analysis of
the distinct bioactivities of different vancomycin variants.
These in vivo analyses not only demonstrated that the
vcm encoded halogenase and methyltransferase are func-
tionally equivalent to those encoded in the bal and cep
clusters, but also inferred that the modifications of
halogenation, methylation, and glycosylation are not
conducted exactly in series [17], because the vanco-
mycin variants produced by each mutant were only
deficient in their corresponding modification princi-
pally (the only exception is aglucovancomycin of the
gtfE mutant, from which both the glycosyl residues were
absent). In other words, the tailoring enzymes (except
GtfD) are not very specific, but have broad substrate spec-
tra in vivo.Conclusions
The genome of A. orientalis HCCB10007 is the first
complete sequence for the bacteria that synthesize the
vancomycin group antibiotics. Compared with the phylo-
genetic closely related rifamycin-producing strain A. medi-
terranei, A. orientalis has a relatively smaller chromosome
and a more compact genomic organization. Their differ-
ent configurations revealed possible chromosomal recom-
bination events representing genomic plasticity related to
either vancomycin biosynthesis or rifamycin biosyn-
thesis. By comparison with other actinomycete genomes,
the common features of the Amycolatopsis genomes and
molecular chemotaxonomic characteristics (MCCs) repre-
senting the phenotypes of phospholipid and mena-
quinone for this genus were further identified and
developed. In addition, the knockout of genes encod-
ing the tailoring enzymes in A. orientalis was achieved,
and the functions of the predicted halogenase and methyl-
transferase annotated in the vcm cluster were charac-
terized for the first time. The data provided by this
study may facilitate the development of novel lead
compounds for drug development, either through a
combinatorial biosynthesis approach employing en-
zymes with newly engineered modification activities,
or using different vancomycin derivatives as the start-
ing chemical moieties.
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Genome sequencing and assembly
A orientalis strain HCCB10007 was deposited in the In-
stitute of Microbiology of Chinese Academy of Sciences
and designated CGMCC No. 6023. A traditional whole
genome shotgun strategy using the Roche 454 GS FLX
Titanium System was applied to sequence HCCB10007’s
genome. In total, 53 contigs with 8.9-Mb length were as-
sembled from 561,423 reads (average length of 408 bp)
by the Newbler Program (version 2.3) of the 454 suite
package. The relationships between the contigs were deter-
mined by referring to the A. mediterranei genome or using
the ContigScape plugin [54], and the remaining gaps were
filled using a multiplex PCR strategy. The final sequence
assembly was performed using the phred/phrap/consed
package (http://www.phrap.org/phredphrapconsed.html).
Sanger-based sequencing was employed to facilitate the gap
closure and to amend the low-quality regions (score < 60).
Finally, a consensus sequence containing 8,948,591 bp
(with an estimated error rate of less than 0.5 per 100,000
bases) that provided 25.6-fold coverage was acquired.
Genome annotation and analysis
Putative protein-coding sequences were predicted based
on the results from both Glimmer and Genemark. The
BLASTP results obtained from the KEGG, NR, and CDD
databases were used to annotate the CDSs and manual
correction was also implemented. The tRNA genes were
predicted directly with tRNAscan-SE v1.23. Essential
genes were defined as those encoding proteins functioning
in cell division, replication, transcription, translation, and
amino-acid metabolism, with reference to the Clusters of
Orthologous Groups (COGs) Database. Unless otherwise
stated, the orthologous proteins between A. orientalis
HCCB10007 and other related species were defined by re-
ciprocal BLASTP under the following conditions: mini-
mum 30% identity and 30% length diversity. The coding
density of all of the genes was defined as the ratio of the
protein-coding sequences (CDSs) length to the total gen-
omic length, whereas the coding density of essential genes
(or orthologs) was defined as the ratio of sequence length
of the essential genes (or orthologs) to the total CDSs in a
corresponding non-overlapping sliding window. Statistical
comparisons between core vs. non-core and quasi-core vs.
non-core were estimated as P-values calculated by the
grouped t test method with the statistical programming
language R, employing two window sizes for analyses
(except for the case of comparing the coding density of
essential genes between quasi-core vs. non-core, P-values
shown in the text used the 90-kb sliding window size in-
stead of 45-kb). The MUMmer 3.0 Project was used to
analyze the genome-wide co-linearity between A. orienta-
lis HCCB10007 and A. mediterranei. To characterize the
molecular chemotaxonomic characteristics (MCCs), thebiosynthetic pathways of arabinose, glycine, diaminopime-
lic acids, mycolic acids, phospholipids, and menaquinones
in A. orientalis and other actinomycetes were analyzed on
http://www.kegg.jp/kegg/pathway.html. Literature search-
ing, sequence alignment, domain comparison, and/or
phylogenetic analysis were used to further identify the
critical genes that determined the existence, conformation,
and chain lengths of compounds. All of the BLASTP ana-
lyses conducted with the MCCs used a threshold E value
of 1e-3. The neighbor joining (NJ) method of the MEGA
5.0 package was used to construct phylogenetic trees
based on the 16S rRNA, Isp, and MurE sequences, and
the reliability of each branch was tested by 1,000 bootstrap
replications. For the Isp sequences, an additional max-
imum parsimony (MP) method was used to obtain a more
robust tree topology. The SBSPKS [45] and/or NRPSDB
[46] databases were used to predict the probable sub-
strates or products for secondary metabolite biosynthetic
gene clusters.
Construction of monogenic mutations of AORI_1485
(vhal), AORI_1490 (vmt), AORI_1486 (gtfD) and AORI_1487
(gtfE) in A. orientalis
A homologous recombination method similar to the
PCR-targeting system applied in Streptomyces was used
to mutate the vhal, vmt, gtfD, and gtfE genes in A. orientalis
HCCB10007. First, a cosmid library of A. orientalis gen-
omic DNA (containing inserts of about 40Kb in length)
was constructed using SuperCos 1 Cosmid Vector Kit
(Agilent Technologies, Inc.). The cosmid clone XL0311,
which contained the AORI_1485, AORI_1490, AORI_1486,
and AORI_1487 genes, was selected by Southern blotting
and further used to knockout vhal, vmt, gtfD, and gtfE,
individually. All of the target genes in XL0311 were re-
placed precisely with the apramycin-resistance gene, using
two long recombinational primers (39 nt). The cosmids
with mutated target genes were introduced into E. coli
BW25113/pIJ790 (λ RED recombination plasmid) and
then conjugated into the A. orientalis recipients. The cor-
rect exconjugants/knockout clones were selected based
on their apramycin resistance (50 μg/ml) on MS medium
(mannose 20 g/L, soybean flour 20 g/L, agar 20 g/L, and
10 mmol/L MgCl2) supplemented with nalidixic acid
(20 μg/ml) for counter selection. The genes inactivated by
homologous recombination were further confirmed by PCR
(for primers, please see Additional file 1: Supplementary
Materials and Methods).
Vmt expression, purification, and in vitro modification
assay
The vmt gene from the A. orientalis HCCB10007 genomic
DNA was cloned into a pET30a vector and transformed
into BL21 (DE3) cells. The expression of His6-tagged Vmt
was induced by 1 mM isopropyl-1-thio-β-D-galactoside
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acid (Ni-NTA) affinity chromatography (Qiagen, Valencia,
CA, USA) was used to purify the protein. The in vitro
methylation modification system contained 2 mM (S)-
adenosyl-L-methionine (Sigma-Aldrich Canada), 10 mM
His6-Vmt (3 mg), 500 mM substrate (demethylvancomy-
cin or aglucovancomycin), and 50 mM Tris-HCl (pH 7.5)
in a total volume of 1 ml. The reaction was conducted at
25°C for 24 h. The reaction was stopped by the addition of
an equal volume of cold methanol, incubated at –20°C for
20 min, and centrifuged for 5 min at 10,000 × g. HPLC-
MS was used to analyze the supernatant.
HPLC-MS analyses
The vancomycin derivatives were prepared from ultra-
sonically lysed suspensions of the culture pellets, and the
cell debris was removed by centrifugation and filtration.
HPLC-Q-TOF-MS (Waters Micromass Q-TOF Premier
Mass Spectrometer) analysis was then used to identify
the derivates. HPLC was performed at 40°C using an
ACQUITY HPLC BEH C18 column (100 mm× 2.1 mm,
i.d.: 1.7 μm; Waters Corp., Milford, USA) equipped with an
ACQUITY HPLC VanGuard PreColumn (5 mm× 2.1 mm,
i.d.: 1.7 μm; Waters Corp., Milford, MA, USA). Solvent A
(0.05% TFA in water) and solvent B (0.05% TFA in aceto-
nitrile) were used as the mobile phase, with a flow rate of
0.4 ml min−1. The following gradient was used: t = 0 min:
5% B; t = 2.2 min: 15% B; t = 4.5 min: 30% B; t = 12.5 min:
99% B. The mass spectrometer detected all of the samples
at a wavelength of 240 nm.
Zone of inhibition test
This test was conducted using Staphylococcus aureus
cultured in LB medium as indicator cells. The soft top
agar of the test agar plate consisted of 10 gL−1 tryptone
extract, 5 gL−1 yeast extract, 5 gL−1 NaCl, and 16 gL−1
agar, and the indicator cells were added into the soft
agar at a final concentration of 106 cfu/ml. Then, 20 μg
of each vancomycin variant was carefully dropped onto
the drug-sensitive slips. The slips were then placed on the
center of the agar plates. Observations were made after
20 hours at 37°C. Three independent experiments were
performed and the representative pictures were chosen
for the figure.
Nucleotide sequence accession numbers
The nucleotide sequences of the chromosome and plas-
mid were deposited in the GenBank database under acces-
sion numbers [CP003410] and [CP003411], respectively.
Availability of supporting data
All the supporting data named as “Additional files for
the Amycolatopsis orientalis genome paper”, were depos-
ited in an open access repository of CHGC (ChineseNational Human Genome Center at Shanghai) database.
Please refer to http://chgc.sh.cn/ch/Ao.html. The phylogen-
etic trees based on the 16S rRNA, Isp, and MurE sequences
were deposited in Treebase database (www.treebase.org).
Please refer to http://purl.org/phylo/treebase/phylows/study/
TB2:S15601.
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P-values derived from grouped t test for the coding densities of orthologs
or essential genes comparing the core (or R1, or R2) region against the
non-core regions under the conditions of different sliding window sizes.
Table S3. Enzymes in different actinomycetes involved in the pathway of
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